Back to User profile » Dr Jingfeng Zong
Papers published by Dr Jingfeng Zong:
Oral Maintenance Chemotherapy Using S-1/Capecitabine in Metastatic Nasopharyngeal Carcinoma Patients After Systemic Chemotherapy: A Single-Institution Experience [Corrigendum]
Guo Q, Chen M, Xu H, Lu T, Zhou H, Chen Y, Zong J, Xu Y, Chen B, Wang B, Zhu L, Pan J, Lin S
Cancer Management and Research 2020, 12:2365-2366
Published Date: 31 March 2020
High Soluble Programmed Death-Ligand 1 Predicts Poor Prognosis in Patients with Nasopharyngeal Carcinoma
Lu T, Chen Y, Li J, Guo Q, Lin W, Zheng Y, Su Y, Zong J, Lin S, Ye Y, Pan J
OncoTargets and Therapy 2020, 13:1757-1765
Published Date: 26 February 2020
Oral Maintenance Chemotherapy Using S-1/Capecitabine in Metastatic Nasopharyngeal Carcinoma Patients After Systemic Chemotherapy: A Single-Institution Experience
Guo Q, Chen M, Xu H, Lu T, Zhou H, Chen Y, Zong J, Xu Y, Chen B, Wang B, Zhu L, Pan J, Lin S
Cancer Management and Research 2020, 12:1387-1396
Published Date: 25 February 2020
Stanniocalcin 2 (STC2) Expression Promotes Post-Radiation Survival, Migration and Invasion of Nasopharyngeal Carcinoma Cells [Corrigendum]
He H, Qie S, Guo Q, Chen S, Zou C, Lu T, Su Y, Zong J, Xu H, He D, Xu Y, Chen B, Pan J, Sang N, Lin S
Cancer Management and Research 2019, 11:10409-10410
Published Date: 11 December 2019
Stanniocalcin 2 (STC2) expression promotes post-radiation survival, migration and invasion of nasopharyngeal carcinoma cells
He H, Qie S, Guo Q, Chen S, Zou C, Lu T, Su Y, Zong J, Xu H, He D, Xu Y, Chen B, Pan J, Sang N, Lin S
Cancer Management and Research 2019, 11:6411-6424
Published Date: 11 July 2019